| Literature DB >> 31491086 |
Ge Li1, Yuantie Zheng1, Jiali Yao1, Linya Hu1, Qunpeng Liu1,2, Furong Ke1, Weixiao Feng1,3, Ya Zhao1,4, Pencheng Yan1, Wenfei He1, Hui Deng4, Peihong Qiu1, Wulan Li3, Jianzhang Wu1.
Abstract
The supplementation of exogenous antioxidants to scavenge excessive reactive oxygen species (ROS) is an effective treatment for cerebral ischemia-reperfusion injury (CIRI) in stroke. Piperlongumine (PL), a natural alkaloid, has a great potential as a neuroprotective agent, but it also has obvious toxicity. Moreover, its neuroprotective effects remain to be improved. In this study, we designed a series of novel PL analogs by hybridizing the screened low-toxicity diketene skeleton with antioxidant effect and the 3,4,5-trimethoxyphenyl group, which may increase the antioxidant activity of PL. The intermediate was synthesized by a novel green synthesis method, and 34 compounds were obtained. The compounds without obvious cytotoxicity have remarkable antioxidant effects, especially compared with diketene skeletons and PL. The cytoprotection of the active compound decreased significantly by reduction of the carbon-carbon double bonds of the Michael acceptor in the diketene skeleton. More importantly, further study revealed that compound A9, which has the best activity, can confer protection for cells against oxidative stress and attenuate brain injury in vivo. Overall, this study provided a promising drug candidate for the treatment of CIRI and guided the further development of drug research in oxidative stress-mediated diseases.Entities:
Keywords: Michael acceptor; Piperlongumine analogs; antioxidation; cerebral ischemia-reperfusion injury; green synthesis; neuroprotection; stroke
Mesh:
Substances:
Year: 2019 PMID: 31491086 DOI: 10.1021/acschemneuro.9b00402
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418